Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Antoaneta Gateva, Adelina Tsakova, Julieta Hristova & Zdravko Kamenov. (2020) Fibroblast growth factor 23 and 25(OH)D levels are related to abdominal obesity and cardiovascular risk in patients with polycystic ovarian syndrome. Gynecological Endocrinology 36:5, pages 402-405.
Read now
Read now
M. N. Gunning & B. C. J. M. Fauser. (2017) Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?. Climacteric 20:3, pages 222-227.
Read now
Read now
Zhou Guoqing, Sun Fang, Duan Lihui, Yan Bing, Peng Qiaoling, Wang Yingting & Liu Jinxia. (2016) Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome. Gynecological Endocrinology 32:8, pages 655-658.
Read now
Read now
Stefano Palomba, Susanna Santagni, Angela Falbo & Giovanni Battista La Sala. (2015) Complications and challenges associated with polycystic ovary syndrome: current perspectives. International Journal of Women's Health 7, pages 745-763.
Read now
Read now
Agnieszka Pazderska & James Gibney. (2015) Metabolic and lipoprotein aspects of polycystic ovarian syndrome. Clinical Lipidology 10:3, pages 281-293.
Read now
Read now
Susan M Sirmans & Kristen A Pate. (2014) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology 6, pages 1-13.
Read now
Read now
Articles from other publishers (38)
Cara G. Elliott, Sol Vidal-Almela, Paula Harvey, Emma O’Donnell, Jennifer L. Scheid, Sarah Visintini & Jennifer L. Reed. (2023) Examining the Role of Physical Activity Interventions in Modulating Androgens and Cardiovascular Health in Postmenopausal Women: A Narrative Review. CJC Open 5:1, pages 54-71.
Crossref
Crossref
Dandan Sun, Yupeng Wu, Mingyan Ding & Fang Zhu. (2022) Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome. Angiology 73:7, pages 622-634.
Crossref
Crossref
Ashley S. KimRobert A. Wild. (2022) A Possible Screening Marker for Cardiovascular Disease in Polycystic Ovary Syndrome. Journal of Women's Health 31:6, pages 751-752.
Crossref
Crossref
Olatokunbo Osibogun, Oluseye OgunmorotiOlamide B. KoladeAllison G. HaysVictor OkunrintemiAnum S. MinhasMartha GulatiErin D. Michos. (2022) A Systematic Review and Meta-Analysis of the Association Between Polycystic Ovary Syndrome and Coronary Artery Calcification. Journal of Women's Health 31:6, pages 762-771.
Crossref
Crossref
Fatemeh Mahboobifard, Maryam Rahmati, Atrin Niknam, Ehsan Rojhani, Amir Abbas Momenan, Fereidoun Azizi & Fahimeh Ramezani Tehrani. (2022) Impact of Polycystic Ovary Syndrome on Silent Coronary Artery Disease and Cardiovascular Events; A Long-term Population-based Cohort Study. Archives of Medical Research 53:3, pages 312-322.
Crossref
Crossref
Eleni Armeni & Irene Lambrinoudaki. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
245
285
.
Florentina Duică, Cezara Alina Dănilă, Andreea Elena Boboc, Panagiotis Antoniadis, Carmen Elena Condrat, Sebastian Onciul, Nicolae Suciu, Sanda Maria Creţoiu, Valentin Nicolae Varlas & Dragoş Creţoiu. (2021) Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology 12.
Crossref
Crossref
Anne-Marie Carreau, Marie-Hélène Pesant & Jean-Patrice Baillargeon. 2020. Insulin Resistance. Insulin Resistance
255
274
.
Courtney A. Penn, Jessica Chan, Clementina Mesaros, Nathaniel W. Snyder, Daniel J. Rader, Mary D. Sammel & Anuja Dokras. (2019) Association of serum androgens and coronary artery calcium scores in women. Fertility and Sterility 112:3, pages 586-593.
Crossref
Crossref
Laura G. Cooney & Anuja Dokras. (2018) Beyond fertility: polycystic ovary syndrome and long-term health. Fertility and Sterility 110:5, pages 794-809.
Crossref
Crossref
Mahija Sahu & Priyadarshini Tripathy. (2018) THE EFFECTS OF TREATMENT WITH ORAL CONTRACEPTIVE PILL CONTAINING ETHINYL ESTRADIOL-CYPROTERONE ACETATE ALONE OR IN COMBINATION WITH METFORMIN ON CLINICAL, HORMONAL, METABOLIC AND ULTRASONOGRAPHIC CHARACTERISTICS IN POLYCYSTIC OVARIAN SYNDROME. Journal of Evidence Based Medicine and Healthcare 5:32, pages 2351-2355.
Crossref
Crossref
Cindy Meun, Oscar H Franco, Klodian Dhana, Loes Jaspers, Taulant Muka, Yvonne Louwers, M Arfan Ikram, Bart C J M Fauser, Maryam Kavousi & Joop S E Laven. (2018) High Androgens in Postmenopausal Women and the Risk for Atherosclerosis and Cardiovascular Disease: The Rotterdam Study. The Journal of Clinical Endocrinology & Metabolism 103:4, pages 1622-1630.
Crossref
Crossref
Unaiza Qamar, Stephen L. Atkin & Thozhukat Sathyapalan. 2018. Practical Guide to Obesity Medicine. Practical Guide to Obesity Medicine
59
70
.
Bart C. J. M. Fauser. 2018. Pre-Menopause, Menopause and Beyond. Pre-Menopause, Menopause and Beyond
119
126
.
Gerbrand A. Zoet, Cindy Meun, Laura Benschop, Eric Boersma, Ricardo P.J. Budde, Bart C.J.M. Fauser, Christianne J.M. de Groot, Aad van der Lugt, Angela H.E.M. Maas, Karl G.M. Moons, Jeanine E. Roeters van Lennep, Jolien W. Roos-Hesselink, Eric A.P. Steegers, Bas B. van Rijn, Joop S.E. Laven, Arie Franx & Birgitta K. Velthuis. (2017) Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study. BMC Women's Health 17:1.
Crossref
Crossref
Priyadarshini Tripathy, Asutosh Sahu, Mahija Sahu & Attila Nagy. (2017) Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 217, pages 18-22.
Crossref
Crossref
Pamela Ouyang, Nanette K. Wenger, Doris Taylor, Janet W. Rich-Edwards, Meir Steiner, Leslee J. Shaw, Sarah L. Berga, Virginia M. Miller & Noel Bairey Merz. (2016) Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists. Biology of Sex Differences 7:1.
Crossref
Crossref
Andromachi Vryonidou, Stavroula A Paschou, Giovanna Muscogiuri, Francesco Orio & Dimitrios G Goulis. (2015) MECHANISMS IN ENDOCRINOLOGY: Metabolic syndrome through the female life cycle. European Journal of Endocrinology 173:5, pages R153-R163.
Crossref
Crossref
Irene Lambrinoudaki. 2015. Early Vascular Aging (EVA). Early Vascular Aging (EVA)
181
194
.
Ronit Calderon-MargalitDavid SiscovickSharon S. MerkinErica WangMartha L. DaviglusPamela J. SchreinerBarbara SternfeldO. Dale WilliamsCora E. LewisRicardo AzzizStephen M. SchwartzMelissa F. Wellons. (2014) Prospective Association of Polycystic Ovary Syndrome With Coronary Artery Calcification and Carotid-Intima-Media Thickness. Arteriosclerosis, Thrombosis, and Vascular Biology 34:12, pages 2688-2694.
Crossref
Crossref
Susan M. SirmansRoy C. ParishSandra BlakeXiaojun Wang. (2023) Epidemiology and Comorbidities of Polycystic Ovary Syndrome in an Indigent Population. Journal of Investigative Medicine 62:6, pages 868-874.
Crossref
Crossref
Jennifer K. Hillman, Lauren N.C. Johnson, Meghana Limaye, Rebecca A. Feldman, Mary Sammel & Anuja Dokras. (2014) Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS. Fertility and Sterility 101:2, pages 530-535.
Crossref
Crossref
Lauren W. Milman & Anuja Dokras. 2014. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
303
316
.
Anuja Dokras. (2013) Cardiovascular disease risk in women with PCOS. Steroids 78:8, pages 773-776.
Crossref
Crossref
JIE-PING ZHU, YIN-CHENG TENG, JIAN ZHOU, WEI LU, MIN-FANG TAO & WEI-PING JIA. (2013) Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring. Acta Obstetricia et Gynecologica Scandinavica 92:2, pages 165-171.
Crossref
Crossref
Erica T. Wang, Ivy A. Ku, Sanjiv J. Shah, Martha L. Daviglus, Pamela J. Schreiner, Suma H. Konety, O. Dale Williams, David Siscovick & Kirsten Bibbins-Domingo. (2012) Polycystic Ovary Syndrome Is Associated with Higher Left Ventricular Mass Index: The CARDIA Women's Study. The Journal of Clinical Endocrinology & Metabolism 97:12, pages 4656-4662.
Crossref
Crossref
Eduardo Reyna-Villasmil, Jorly Mejia-Montilla, Duly Torres-Cepeda, Joel Santos-Bolívar, Jhoan Aragon-Charrys, Nadia Reyna-Villasmil & Alfonso Bravo-Henríquez. (2012) Efecto de las hormonas sexuales sobre las concentraciones de homocisteína en preeclámpticas y embarazadas normales. Progresos de Obstetricia y Ginecología 55:5, pages 226-231.
Crossref
Crossref
Susan Maureen Sirmans, Emily Weidman-Evans, Victoria Everton & Daniel Thompson. (2012) Polycystic Ovary Syndrome and Chronic Inflammation: Pharmacotherapeutic Implications. Annals of Pharmacotherapy 46:3, pages 403-418.
Crossref
Crossref
Michelle L. Meyer, Angela M. Malek, Robert A. Wild, Mary T. Korytkowski & Evelyn O. Talbott. (2012) Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 18:2, pages 112-126.
Crossref
Crossref
Bart C.J.M. Fauser, Basil C. Tarlatzis, Robert W. Rebar, Richard S. Legro, Adam H. Balen, Roger Lobo, Enrico Carmina, Jeffrey Chang, Bulent O. Yildiz, Joop S.E. Laven, Jacky Boivin, Felice Petraglia, C.N. Wijeyeratne, Robert J. Norman, Andrea Dunaif, Stephen Franks, Robert A. Wild, Daniel Dumesic & Kurt Barnhart. (2012) Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 97:1, pages 28-38.e25.
Crossref
Crossref
D.T.M. Ngo, W.P. Chan, S. Rajendran, T. Heresztyn, A. Amarasekera, A.L. Sverdlov, P.D. O’Loughlin, H.A. Morris, Y.Y. Chirkov, R.J. Norman & J.D. Horowitz. (2011) Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 25:3, pages 326-330.
Crossref
Crossref
Mary P. McGowan. (2011) Polycystic Ovary Syndrome: A Common Endocrine Disorder and Risk Factor for Vascular Disease. Current Treatment Options in Cardiovascular Medicine 13:4, pages 289-301.
Crossref
Crossref
Rhonda Bentley-Lewis, Ellen Seely & Andrea Dunaif. (2011) Ovarian Hypertension: Polycystic Ovary Syndrome. Endocrinology and Metabolism Clinics of North America 40:2, pages 433-449.
Crossref
Crossref
Denise Prado Momesso, Isabela Bussade, Marcio Antonio Epifanio, Claudio Domenico Sahione Schettino, Luis Augusto Tavares Russo & Rosane Kupfer. (2011) Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome. Diabetes Research and Clinical Practice 91:1, pages 47-53.
Crossref
Crossref
Antoni J. Duleba & Ibrahim M. Ahmed. (2010) Predictors of urinary albumin excretion in women with polycystic ovary syndrome. Fertility and Sterility 93:7, pages 2285-2290.
Crossref
Crossref
Charles J. Glueck, John A. Morrison, Naila Goldenberg & Ping Wang. (2009) Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population. Metabolism 58:5, pages 714-721.
Crossref
Crossref
C.J. Glueck, N. Goldenberg & P. Wang. (2009) Metformin-Diet Ameliorates Coronary Heart Disease Risk Factors and Facilitates Resumption of Regular Menses in Adolescents with Polycystic Ovary Syndrome. Journal of Pediatric Endocrinology and Metabolism 22:9.
Crossref
Crossref
Richard S. Legro. (2008) Polycystic ovary syndrome and cardiovascular disease risk. Current Cardiovascular Risk Reports 3:1, pages 65-70.
Crossref
Crossref